Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? (Q34749837)

4 August 2017

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? (English)

1 reference

4 August 2017

A F Lever

1

1 reference

4 August 2017

D J Hole

2

1 reference

4 August 2017

C R Gillis

3

1 reference

4 August 2017

I R McCallum

4

1 reference

4 August 2017

G T McInnes

5

1 reference

4 August 2017

P L MacKinnon

6

1 reference

4 August 2017

P A Meredith

7

1 reference

4 August 2017

L S Murray

8

1 reference

4 August 2017

J L Reid

9

1 reference

4 August 2017

J W Robertson

10

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

4 August 2017

1 reference

4 August 2017

352

1 reference

4 August 2017

179-184

1 reference

4 August 2017

9123

1 reference

Do calcium channel blockers increase the risk of cancer?

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Calcium-channel blockade and incidence of cancer in aged populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Calcium-channel blockers and risk of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Cancer risk in users of calcium channel blockers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Cancer risk of hypertensive patients taking calcium antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Angiotensin II type 1 receptor expression in human breast tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Signal transduction pathways of angiotensin II--induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Mortality in patients of the Glasgow Blood Pressure Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Incidence of and mortality from cancer in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Blood pressure in a Scottish town

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Cancer and hypertension. An unresolved issue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

You cannot exclude the explanation you have not considered

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Failed or misleading adjustment for confounding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

Australian comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly (ANBP2): objectives and protocol. Management Committee on behalf of the High Blood Pressure Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903228-0

7 January 2021

10.1016/S0140-6736(98)03228-0

Identifiers

DOI

1 reference

4 August 2017

1 reference